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 Intellectual Property Rights and Crop-Improving R&D under Adaptive Destruction 
 
Abstract 
This paper studies how the strength of intellectual property rights (IPRs) affects investments 
in biological innovations when the value of an innovation is stochastically reduced to zero 
because of the evolution of pest resistance. We frame the problem as a research and 
development (R&D) investment game in a duopoly model of sequential innovation. We 
characterize the incentives to invest in R&D under two competing IPR regimes, which differ 
in their treatment of the follow-on innovations that become necessary because of pest 
adaptation. Depending on the magnitude of the R&D cost, ex ante firms might prefer an 
intellectual property regime with or without a “research exemption” provision. The study of 
the welfare function that also accounts for benefit spillovers to consumers—which is 
possible analytically under some parametric conditions, and numerically otherwise—shows 
that the ranking of the two IPR regimes depends critically on the extent of the R&D cost.  
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1. Introduction 
A major objective of crop breeding has long been that of improving the resistance of 
commercial varieties to pests, diseases, and environmental stresses, which are known to 
cause significant yield reductions. For U.S. agriculture alone, it is estimated that the damage 
ranges between $2 billion and $7 billion per year, with an additional $1.2 billion spent on 
various crop protection measures (Palumbi, 2001). The task of improving crop resistance, 
however, is particularly challenging because the evolution of pest species makes possible the 
emergence of resistance in the pest population, which leads to the obsolescence over time of 
past improvements. This calls for continuing and sustained research and development 
(R&D) efforts, combining both traditional breeding and newer biotechnology tools, aimed at 
crop improvements. Furthermore, in an era of declining public support for agricultural 
research, it is imperative that private R&D activities be encouraged and fostered by suitable 
policies. In this paper we focus on the role of intellectual property rights, and specifically 
investigate some implications that arise in the context of innovations that may be rendered 
ineffective over time because of the onset of pest resistance.  
Whereas agricultural biotechnology promises new, powerful tools for crop 
improvement, the possibility of unintended or unforeseen consequences suggests that some 
form of government regulation might be necessary (Just, Alston, and Zilberman, 2006; 
Swanson, 2002). One way to address biotechnology policy issues is through a general 
economic approach to the optimal management of biological resources that includes 
methods for valuing existing species in the context of maximizing expected social welfare 
(Brock and Xepapadeas, 2003). This approach has been used extensively to study the 
dynamics of the pest adaptation process, and it is often argued that some form of policy 
intervention may improve welfare because farmers generally lack incentives to take into 
account the consequences of their pest management practices, including planting decisions. 
For this reason, the U.S. Environmental Protection Agency has introduced in some cases (in 
particular in the cases of Bt cotton and Bt corn) regulations that require farmers to plant at 
least some of their land with crops that are not genetically modified (GM) to slow down the 
rate of resistance development (Fisher and Laxminarayan, 2005). Such policies are usually 
analyzed in a bioeconomic model that takes into account interplay between the evolutionary 
adaptation by pests and economic incentives of farmers (Hurley et al., 2002).  
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The effectiveness of such policy creating “crop refuges” has been questioned on 
purely biological grounds, as well as more generally. Specifically, it has been argued that 
private breeders should have an incentive to take into account the problem of the evolution 
of pest resistance, because this process directly affects their profits (Noonan, 2002). Thus, 
private breeders would ensure that existing pest management techniques are used efficiently 
and would invest in the development of new technologies to overcome the resistance 
problem (Fisher and Laxminarayan, 2004).  
The literature on optimal resistance management has been of interest for both pest 
resistance in agriculture and antibiotics resistance in public health, and it is now well 
understood that economics can be useful in understanding various forms of externalities in 
both cases (Goeschl and Swanson, 2002a). The economic approach to pest resistance 
management in agriculture was pioneered by Hueth and Regev (1974). Subsequent studies 
on the excessive use of pesticides and the possibility of market failure when dealing with the 
pest resistance problem has yielded important insights, but some see a need to move beyond 
the renewable/nonrenewable resource framework that has been used so far and to consider 
other important features of the economic environment (Alix-Garcia and Zilberman, 2005). 
In particular, the incentive of private sector breeders to invest in crop innovations depends 
on the delineation of property rights in the various attributes of the new crop varieties, and, 
therefore, the issues of intellectual property rights and the resulting market structure should 
occupy a central place in this debate.  
Existing research on the interplay between social and private incentives to innovate 
in the context of the resistance problem leads to some interesting conclusions. First, while 
society as a whole reaps a large benefit from technologies that decrease the scope of the 
resistance problem, the benefits are dissipated among many users and thus may not attract 
sufficient private investments. This point was made by Goeschl and Swanson (2003b), who 
also note that the nature of innovation in the context of a biological race against nature 
differs from that of the standard quality ladder model of many innovation and growth 
models. They coined the term “adaptive destruction” to characterize this process, 
emphasizing the analogy to and difference from the Schumpeterian paradigm of “creative 
destruction” (in which each product is eventually superseded by a higher-quality one). 
Second, as shown by Goeschl and Swanson (2003a), private and social incentives to invest in 
R&D might diverge with an increase in the degree of adaptive destruction, because the more 
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severe is the resistance problem, the lower is the private benefit of crop R&D and the higher 
are the social returns from such investment. Goeschl and Swanson (2002b), in the context of 
an R&D race with antibiotic resistance, similarly find that private incentives fall short of 
generating the first-best outcome.   
In this paper we explore in more detail how the form and extent of intellectual 
property rights (IPRs) impact the incentive to innovate and the welfare consequences of 
innovation, in a context characterized by adaptive destruction. Moschini and Yerokhin 
(2006) show that a particularly useful characterization of the strength of IPRs for plants 
consists of whether or not such IPRs contain a “research exemption” or “experimental use” 
provision. Following that approach, here we compare and contrast the effects of two 
alternative IPR regimes that capture some essential features of the current institutional 
setting. The “stronger” IPR mode, referred to as the full patent (FP) regime, corresponds to 
the standard utility patents (as awarded in the United States by the U.S. Patent and 
Trademark Office). The relatively “weaker” IPR mode, referred to as the research exemption 
(RE) regime, corresponds to the so-called plant breeders’ rights (PBRs). As we will discuss in 
more detail, the critical difference between these two IPR modes concerns a feature that 
bears on the sequential and cumulative nature of innovation, which is a distinctive feature of 
agricultural and biotechnology innovations.   
In addition to the consideration of alternative IPR regimes, in our analysis we also 
emphasize the importance of the market structure of the innovation industry, a feature 
largely ignored to date in the analysis of the biological resistance problem. In particular, we 
build a duopoly model of an R&D race in which the value of the final product is destroyed 
with exogenously given probability, thus making the duration of the monopoly power finite 
even under the (simplifying) assumption of an infinite patent life. Conceptually, this model 
belongs to the class of symmetric stochastic R&D races in which innovations arrive 
according to a Poisson process (Reinganum, 1989, provides an early survey of this literature). 
In addition to addressing the resistance problem, our analysis contributes to the literature on 
IPR incentives for sequential innovation. Models in this area typically consider the effects of 
patent length and breadth on the division of profit between the owners of the first and 
second generations of innovation, both in a sequential setting (Green and Scotchmer, 1995) 
and in the context of R&D races (O’Donoghue, 1998; Denicolò, 2000). In contrast to most 
of these models, we assume that the second generation of the innovation is patentable and 
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non-infringing, and we concentrate on the question of whether the first innovator has the 
right to block all further R&D activities related to the patented product (i.e., whether or not 
there exists a research exemption).  
In our setting, under the FP regime, the research on the patented product constitutes 
an infringement. Because of the sequential nature of the innovation process, with this kind 
of IPR protection the winner of the first race obtains an exclusive right to improve the 
product in the future. On the other hand, under the RE regime, firms cannot be excluded 
from participating in any improvement project, so that each improvement stage is a race 
between two firms. Throughout the analysis, we assume that no licensing takes place, in 
order to emphasize the effects of the IPR regimes on the incentives for innovation. In the 
next section, we provide a brief background that illustrates some critical features of our 
stylized model. We then describe the demand side of the model and lay out the structure of 
the R&D model that embeds, among other things, the notion of adaptive destruction. We 
characterize the Markov perfect equilibria that arise and study the incentive and welfare 
effects of the two IPR regimes of interest.  
 
2. IPRs and Crop-Improving R&D in Agriculture  
The need to account explicitly for the nature of IPRs is given more urgency by the dramatic 
changes that have characterized the R&D enterprise in crop improvements and 
biotechnology over the last quarter of a century. Intellectual property protection in these 
areas has been strengthened enormously, leading to what amounts to a revolution in the set 
of opportunities facing innovators (Wright and Pardey, 2006). In the United States, 
following the 1980 landmark U.S. Supreme Court decision in Diamond v. Chakrabarty, a major 
change has been the extension of the applicability of standard utility patents to virtually any 
biologically based invention, if obtained through human intervention. That utility patents can 
be used for the products of plant breeding and biotechnology in agriculture was confirmed 
by the 2001 U.S. Supreme Court ruling in J.E.M. Ag Supply, Inc. v. Pioneer Hi-Bred International, 
Inc., which held that plant seeds and plants themselves (both traditionally bred or produced 
by genetic engineering) are patentable under U.S. law (Janis and Kesan, 2002).  
Whereas the availability of utility patents for plant and animal innovations has also 
been introduced in many other developed countries, in most developing countries PBRs 
remain the strongest IPR protection instrument available. Indeed, in the international 
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context the impetus to harmonize and strengthen IPRs in agriculture has resulted from the 
implementation of the TRIPS (trade related aspects of intellectual property rights) agreement 
of the World Trade Organization (WTO) (Moschini, 2004). A crucial feature of TRIPS is 
that it mandates that minimum standards of IPR protection be provided by each WTO 
member in each of the main areas of intellectual property that it covers. Specifically, patent 
protection must be accorded for both products and processes, for at least 20 years, in almost 
all fields of technology. But agriculture-related innovations enjoy a somewhat special 
treatment within TRIPS because plant and animal innovations need not be protected by 
patents, as long as a suitable sui generis protection is offered. Modern agriculture-related R&D 
relies heavily on biotechnology innovations, as in the development of GM crop varieties, and 
it turns out that the flexibility provided by TRIPS extends further than plant and animal 
innovation: “essentially biological processes” may also be excluded from patentability 
(although patents must be provided for microorganisms, and for microbiological processes 
for producing plants or animals). 
As noted, if plants and animals are excluded from patentability, then under TRIPS a 
sui generis IPR system must be provided. PBRs are commonly used internationally for plant 
varieties and appear to be the sui generis IPR system of choice for many countries, including 
virtually all developing countries. But, unlike utility patents, PBRs allow for a well-defined 
“research exception.” That is, a protected variety may be used by others in their breeding 
programs aimed at developing a new variety. Thus, PBRs are clearly a weaker IPR protection 
instrument than patents, and whether the feature that separates these two IPR protection 
modes has important consequences for the innovation enterprise appears to be an important 
and yet unsettled question.  
Concomitant with the rise of the importance of IPRs for agricultural R&D, the last 
few decades have also witnessed a number of other critical developments. The secular trend 
in the decline of public R&D relative to private R&D (Fuglie et al., 1996) has intensified, and 
at present the private sector provides the bulk of biological research efforts in agriculture. 
Furthermore, the agricultural seed and chemical industries have undergone a tremendous 
consolidation. The earlier emphasis on the “life sciences” concept was abandoned because 
of a perceived lack of sufficient synergies between plant and human-health biotechnology. 
What has emerged, instead, is a strong consolidation between the seed and the agrochemical 
industrial segments aimed at exploiting the way modern GM varieties can complement 
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and/or substitute for more traditional herbicide and pesticide products. A wave of 
acquisitions has resulted in a highly concentrated and integrated agro-chemical sector 
(UNCTAD, 2006).  
In what follows, we develop a stylized model of innovation that features the 
biological resistance problem and the notion of adaptive destruction, and we do so in a more 
realistic institutional context that is consistent with the critical role played by IPRs and the 
market structure of the relevant industry. In particular, we compare and contrast the effects 
of two IPR regimes that differ precisely with respect to the presence of a research 
exemption, and, based on the foregoing discussion of consolidation in the agro-chemical 
sector, we cast the analysis in an imperfectly competitive setting (specifically, a duopoly).  
 
3. A Model of Sequential Innovation 
We imagine a situation in which a biological innovation, such as an improved seed variety 
resistant to a particular pest, can be developed upon a costly and risky R&D process. Once 
developed, this innovation is adopted by a competitive sector, which we represent as made 
up of heterogeneous agents (e.g., farmers), that is, a population of potential costumers with 
differing willingness to pay for the innovation. Consistent with the notion of adaptive 
destruction discussed in the introduction, we also postulate that the value of the innovation 
is stochastically reduced to zero as time goes by. After the value of the existing innovation is 
thus destroyed, a new R&D process can start to re-introduce the resistance trait of interest 
into the variety. Whether both firms can take part in this new innovation effort or only the 
firm that developed the improved variety in the initial innovations state depends on the 
nature of the IPR system. With an RE regime, both firms can participate in follow-on 
research. But if the IPR system does not allow for a research exemption (i.e., the FP regime), 
then we presume that only the winner of the initial stage can engage in efforts to restore the 
value of the variety after the onset of pest resistance. In either case, the winner of each race 
becomes the monopolist for the duration of the period in which innovation has a positive 
market value. 
 
3.1. Demand for innovation 
The derived demand ( )D p  for the innovated product protected by IPRs is presumed 
downward sloping, as in Figure 1, where v  denotes the choke price. Given the exclusivity 
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afforded by IPRs, the innovator can price monopolistically at Mp  so that, at the quantity 
demanded by users at that price, the marginal production cost mc  equals the marginal 
revenue mr . Ex post, therefore, the innovator can extract a profit equal to π  (the green area 
in Figure 1), but some of the innovation’s benefits also accrue to users, and relative to the ex 
post first-best use of the innovation there is also a deadweight loss—these two effects are 
labeled cs  and dwl  in Figure 1 (e.g., Langinier and Moschini, 2002). To make the model 
tractable, we specifically postulate that there is a unit mass of end-users whose valuation of 
the new product is distributed uniformly on the interval [0, ]v . For any given price of a new 
product, only users with valuations above that price will make a purchase. This implies that 
the monopolist faces a linear demand function of the form = −( ) 1 /D p p v . If the marginal 
cost of production is constant, as in Figure 1, then without further loss of generality we can 
write = 0mc . Under these assumptions, the monopolist’s profit per unit of time is given by 
π = / 4v . Given this simplified demand structure, the surplus accruing to consumers under 
this (uniform) monopolistic pricing satisfies π= / 2cs .  
 
Figure 1. Demand for innovation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v
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dwl
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3.2. Stochastic production of innovation 
At the start of the R&D contest, or after the value of innovation is reduced to zero, the 
firms engage in an R&D race in which the time of discovery is stochastic. As in other 
strategic R&D models (e.g., Reinganum, 1989), we assume that innovations arrive according 
to a Poisson process with arrival rate x . Specifically, each firm that incurs a fixed R&D cost 
c  at the start of a race has an instantaneous probability of producing a new product equal to 
x  (Denicolò, 1999), and the resulting stochastic time of the arrival of the innovation τ ( )x  is 
distributed independently with the (exponential) cumulative distribution function given by 
[ ]τ ≤ = − −Pr ( ) 1 exp( )x z xz . 
The expected profit of a firm, when the total number of R&D firms is equal to n , is 
derived in the standard fashion as follows. Denote by τ j  the random time of arrival of 
innovation for firm = 1,2,...,j n  and let τ τ≠=ˆ min{ }i jj i . Then the probability that at least one 
of firm i’s rivals has made a discovery at time z  is given by [ ]τ − −≤ = − ( 1)ˆPr 1 n xzi z e . If we let 
W  denote the prize to the winner of the race and r  denote the common discount rate of all 
firms, the expected profit of firm i  when n  firms participate in the R&D contest is obtained 
by integrating stochastic future returns with the joint density of τ τˆ( , )i i  over the support in 
which τ τ≤ ˆi i , that is, 
∞ ∞ − − − −= − −∫ ∫0 ( 1)
0
( 1)rs n xz xsi
s
V e Wx n e xe dzds c      (1) 
where, again, c  is the fixed R&D cost.  Thus, upon evaluating the integrals in (1), we obtain 
= −+
0
i
xWV c
nx r
.        (2) 
 
3.3. Adaptive destruction 
A critical element of our model is the explicit modeling of the possible devaluation of the 
innovation due to pest adaptation. Such an “adaptive destruction” feature is captured by 
postulating that the value of the new product can be reduced to zero at each point in time 
with instantaneous probability b . That is, the stochastic arrival of adaptive destruction time 
τAD  is distributed exponentially so that [ ]τ ≤ = − −Pr 1 exp( )AD z bz . Admittedly, this 
convenient way to parameterize adaptive destruction is somewhat special, and there are 
 9 
other reasonable ways to model this process. First, we abstract from the possibility that 
adaptive destruction can be affected by some variables endogenous to the model (e.g., 
adoption). Such an extension is not crucial in our setting because we do not emphasize the 
diffusion phase of innovation but instead focus on the R&D strategic interactions brought 
about by different IPR regimes. Second, a more realistic specification would perhaps assume 
that the instantaneous probability of destruction is increasing with time, so that the longer a 
variety is on the market, the higher is the likelihood of pest resistance making it obsolete. As 
explained in more detail in the next section, however, given the assumed structure of R&D 
competition between firms, neglecting the possibility that the probability of resistance 
changes over time does not entail further loss of generality.  
 
4. Duopoly Model of Innovation 
As noted in the introduction, we capture the imperfectly competitive industry structure by 
postulating that there are at most two firms in any stage of the game. At the beginning of 
each stage, both firms decide whether to take part in the race. The winner of each race 
obtains IPRs that afford exclusivity in the final product market. Upon the onset of adaptive 
destruction, leading to the loss of market value for the innovated product, the race to 
produce a new product starts again. In this setting we interpret the RE regime as allowing 
both firms to enter the improvement race after the value of the innovated crop variety has 
been reduced to zero by adaptive destruction. Similarly, we interpret the stronger FP regime 
as restricting access to the improvement stage that follows adaptive destruction, so that only 
the winner of the first race has the right to practice the innovation for subsequent 
improvements. These interpretations are certainly consistent with the distinction between 
PBRs and patents discussed in the introduction, namely, that a patent gives full control of 
the improved variety to the innovator whereas PBRs allow others to use the variety for the 
development of further improvement. In what follows, we characterize the symmetric 
stationary equilibrium of the infinite horizon game under these two IPR regimes. 
 There are two assumptions in our model that make it tractable and may deserve 
further discussion. The first, and the most restrictive one, is the assumption on the timing of 
the R&D process: under the RE regime, a firm can start a new R&D project only when the 
value of the previous innovation is reduced to zero. While assuming that a new R&D project 
can be started at any point in time, after the previous inventive step was made, may appear 
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more realistic, it would also complicate the analysis considerably. In order to focus on the 
sequential nature of innovation and its implications in the adaptive destruction context, we 
choose to abstract from the timing considerations by assuming that firms cannot preempt 
each other in the R&D process.   
The second simplifying assumption, mentioned in the previous section, is that of a 
constant hazard rate for the adaptive destruction process. This modeling choice is less 
restrictive than it might appear when one considers the implications of the previous 
assumption (on the timing of the R&D race). In particular, because the timing of R&D 
investment is exogenous, introducing the hazard function that is increasing in time is 
equivalent to simply decreasing the expected flow of profit from each innovation uniformly 
across the two IP regimes.  While such a change will have an impact on the incentive to 
invest under the RE and FP regimes, there is an equivalent and more economical way to 
study this effect: one can increase the discount rate or the (constant) destruction hazard rate 
and compare the social ranking of the two IP regimes. This is, in fact, one of the 
comparative static exercises that we consider in our welfare analysis.  
 
4.1. Research exemption 
Under an RE regime, both firms can enter the race after the value of the crop has been 
reduced to zero. This implies that the game is essentially a sequence of identical races with 
two firms in each contest. The solution concept we employ in this paper is that of a Markov 
perfect equilibrium; i.e., we assume that strategies of the firms can depend only on the 
current state of the game (Fudenberg and Tirole, 1991). Let σ σ ∈ ×( , ) [0,1] [0,1]i j  denote a 
stationary strategy profile of this game and let σ σ0( , )i jV  denote the expected payoff of firm 
i  at the beginning of the race (i.e., when no firm has yet produced an innovation). Upon 
arrival of the innovation, the successful firm (which we label the “leader”) can market the 
innovation. But because of the adaptive destruction feature discussed earlier, the value of 
this innovation is eventually destroyed. When that happens, a new innovation race can start, 
and under the RE regime both firms can participate. This means that the firm that is not 
successful in the firm innovation (which we label the “follower”) still obtains value from the 
opportunity to take part in future innovation rounds. Thus, let σ σ( , )L i jV  and σ σ( , )F i jV  
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denote the expected payoffs of firm i  when it is the leader and when it is the follower, 
respectively. Then these functions are determined by the following conditions: 
σ σ σ σσ σ σ σ
σ σ σ σσ σ σ σ
+⎛ ⎞= −⎜ ⎟+⎝ ⎠
⎛ ⎞+ − + − −⎜ ⎟+ +⎝ ⎠
0
( , ) ( , )
( , )
2
( , ) ( , )
(1 ) (1 )
L i j F i j
i j i j
F i j L i j
i j j i
xV xV
V c
x r
xV xV
c
x r x r
  (3) 
( )σ σ π σ σ σ σ= + −0( , ) ( , ) ( , )L i j i j L i jrV b V V      (4) 
( )σ σ σ σ σ σ= −0( , ) ( , ) ( , )F i j i j F i jrV b V V .     (5) 
Equation (3) is the expected profit of firm i  for a given strategy profile σ σ( , )i j . 
Equation (4) is a standard Bellman equation, which says that the instantaneous return to 
being the innovation leader in this duopoly equals the flow of profit π  from marketing the 
innovation while it obtains plus the expected loss of value caused by the possibility of 
adaptive destruction. The Bellman equation (5) exhibits the property that there is value to 
being in this duopoly industry, even without any marketable product, because the possibility 
of adaptive destruction entails (in the RE regime) the possibility of taking part in future (and 
potentially profitable) R&D contests.  
Equations (3)-(5) allow us to derive the Markov perfect equilibrium (MPE) of the 
game under the RE regime. It turns out that the equilibrium behavior of firms depends on 
how the cost-to-profit ratio πc  relates to the following threshold levels: 
≡ + +1 ( )(2 )
RE xt
r b x r
       (6) 
≡ + +0 ( )( )
xt
r b x r
.      (7) 
Given that, the following proposition characterizes the MPE of the game under the RE 
regime. 
 
Proposition 1. The symmetric MPE under the RE regime is given by the 
strategy profile ( )σ σ,RE RE  that satisfies the following conditions:   
(i)  If π ≤ 1
REc t  then σ = 1RE . 
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(ii)  If π< <1 0
RE ct t  then σ ∈(0,1)RE . 
(iii)  If π ≥ 0
c t  then σ = 0RE . 
 
A detailed proof of this result is provided in the Appendix, which also reports an explicit 
expression for the σRE  that applies to the case (ii). The structure of equilibrium under the 
RE regime is summarized graphically in the top part of Figure 2. Intuitively, both  1REt  and 
0t  decrease in the discount and adaptive destruction rates, the higher values of which 
decrease expected profit and consequently incentives to invest in R&D. 
The fact that the two firms are ex ante identical justifies interest in the symmetric 
MPE. In such a context, a pure-strategy equilibrium in which both firms invest with 
probability one emerges when the R&D cost c  is sufficiently low (relative to the per-period 
payoff π ), that is, when π ≤ 1REc t . Similarly, when the R&D cost is too high, that is, when 
π ≥ 0c t , both firms abstain from investing. For intermediate values of the R&D cost, that is, 
when π< <1 0REt c t , either firm would be willing to invest if the other firm did not, and 
would prefer to not invest if the other firm did. In addition to such asymmetric pure-strategy 
equilibria, there is a symmetric mixed-strategy MPE in which each firm invests with 
probability σ ∈(0,1)RE , as per Proposition 1. The particular value of this probability, as well 
as the value of the threshold levels 1REt  and 0t , of course depends on the primitive 
parameters of the model (i.e., the Poisson arrival rates x  and b , and the discount rate r ). 
 
4.2. Full patent  
Under the FP regime, the winner of the first race is the only one who has the right to 
practice the innovation for subsequent improvements. Let mV  denote the value to the 
monopolist who has the property rights for the (existing) improved variety that is sold in the 
market, and let 0FPV  denote the expected profit of the firm that has the exclusive right 
(because of the FP regime) to engage in the R&D process in order to produce the next 
generation of a product. Recalling equation (2), these value functions must satisfy  
 = −+0
FP mxVV c
x r
         (8) 
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as well as the asset equation 
 ( )π= + −0FPm mrV b V V .       (9) 
Solving for the value functions, we obtain  
 π − += + + −
( )( )
( )( )m
bc x rV
r b x r bx
,       (10) 
 π − − + + −= + + −0
( ) ( )( )
( )( )
FP bc x c r b x r bxV
r b x r bx
.      (11) 
Recall that under the FP regime there is only one race at the start of the game, the 
winner of which will exclude the other firm from trying to improve the product in the 
future. In order to solve for the equilibrium we need to find the optimal strategies of the two 
firms in the initial race.  It turns out that the equilibrium behavior of firms depends on how 
the cost-to-profit ratio πc  relates to 0t  as defined in equation (7) and to the following 
threshold level:  
+≡ + + + + +1
( )
(2 )( ) ( )
FP x x rt
x r x r b r bx x r
.    (12) 
Given that, the equilibrium under the FP regime is described in the following proposition. 
 
Proposition 2. The symmetric MPE under the FP regime is given by the 
strategy profile ( )σ σ,FP FP  that satisfies the following conditions:  
(i) If π ≤ 1
FPc t  then σ = 1FP . 
(ii) If π< <1 0
FP ct t  then σ ∈(0,1)FP . 
(iii) If π ≥ 0
c t  then σ = 0FP . 
 
A detailed proof of this result is provided in the Appendix, which also reports an explicit 
expression for the σFP  that applies to the case (ii). The structure of this equilibrium is 
illustrated in the bottom part of Figure 2.  
As for the case of the RE regime, we find that the symmetric MPE can involve pure 
strategies with both firms investing when the R&D cost is low enough (relative to the per-
period payoff π ), or with both firms not investing when the R&D cost is too high. For a 
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specific domain of the cost-to-profit ratio, specifically π< <1 0FPt c t , the two firms follow an 
equilibrium mixed strategy. It is informative to observe the relationship between threshold 
levels under the two regimes. First, note that the parameter 0t  is common to both regimes. 
Next, from the expressions given in (6) and (12) it can be verified that >1 1FP REt t . This result 
is intuitive because it implies that the level of the cost-to-profit ratio at which both firms 
start to invest with probability one is higher when the winner becomes a monopolist in the 
improvement game. A comparison of the two IPR regimes’ equilibria is given in Figure 2.  
 
Figure 2. Equilibria under the two IPR alternatives 
 
 
 
 
 
 
 
 
 
 
5. Comparing IPR Alternatives: Ex Ante Profits 
Having characterized the various equilibria that can emerge in our R&D model, we can now 
compare the economic implications of the two IPR regimes of interest. Consider first the ex 
ante expected payoff to the two firms. When firms follow a non-degenerate mixed strategy, 
they must be indifferent between the actions upon which they are randomizing. Given that 
not investing entails a zero expected payoff, it follows that the expected payoff of a mixed 
strategy that assigns nonzero probability to not investing is itself zero. Hence, we know that 
(a) in the interval 1 0[ , ]FPt t , profits are zero under both IPR regimes; (b) in the interval 
1 1[ , ]
RE FPt t , profits are zero under the RE regime, and positive under the FP regime; and (c) in 
the interval 1[0, ]REt , profits are positive under both IPR regimes. 
c
π
1
REt 1
FPt 0t
Research
Exemption:
Full
Patent:
Both
Invest Mixed Strategy No Investment
Both Invest Mixed 
Strategy
No Investment
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In the interval 1[0, ]FPt , both firms invest with probability one under the FP regime. 
Recalling equation (2), the ex ante expected profit of each firm in this case is given by 
Π = −+0 2
FP mV x c
x r
        (13) 
where mV  is the value of being the monopolist of the innovation (and of the right to pursue 
further innovations, upon the onset of pest resistance), as defined earlier. By using equation 
(10) we find that the ex ante expected profit can be written as πα βΠ = −0FP FP FPc , where 
 α +≡ + + +
( )
(2 )( )FP
x x r
x r r b x r
       (14) 
and β α≡ +1FP FPb . 
Similarly, in the interval 1[0, ]REt , both firms invest with probability one under the RE 
regime. By using the expression of the proof of Proposition 1 in the Appendix, when 
σ σ= = 1i j , the ex ante expected profit of each firm can be written as πα βΠ = −0RE RE REc , 
where  
α ≡ + +(2 )RE
x
x r b r
        (15) 
β + +≡ + +
(2 )( )
(2 )RE
x r r b
x r b r
.        (16) 
From the foregoing equations it follows that α α>RE FP , and also that β β>RE FP .  It follows 
that, for a given π , for low values of the cost parameter c , the ex ante expected profit is 
higher under the RE regimes, whereas for higher values of the cost parameter, the FP regime 
yields higher ex ante expected profit.  More specifically, the ranking of ex ante expected profit 
under the two IPR regimes can be summarized as in the following proposition. 
 
Proposition 3. The firm’s expected profit under the RE regime is higher than 
the expected profit under the FP regime if and only if α απ β β
−≤ ≡−
?RE FP
RE FP
c t . 
 
Figure 3 illustrates the expected profit functions under the two IPR regimes for a 
given level of the per-period profit (i.e., varying only the cost parameter while keeping the 
profit parameter fixed). In this graph, the threshold ?t , as defined in Proposition 3, is the 
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point at which Π = Π0 0RE FP . As established in Proposition 3, Figure 3 shows that firms will ex 
ante prefer the RE regime—the weaker of the two IPR regimes—if c is low enough, that is, 
as long as π ≤ ?c t .  
 
Figure 3. Comparison of ex ante profits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The intuition for this result can be obtained by considering the objective functions of 
each firm under the two IPR regimes when both firms invest with probability one in 
equilibrium, which happens in the interval ?[0, ]t . From equation (3) we know that when 
both firms invest with probability one, the ex ante expected profit can be written as 
( )+Π = −+0
2 0.5 (1,1) 0.5 (1,1)
2
L FRE x V V c
x r
      (17) 
where (1,1)LV  and (1,1)FV  are defined in equations (4) and (5). Note that this can be 
interpreted as if each firm could pay amount c  to get a lottery with equal chances of 
becoming the leader and the follower, with corresponding expected payoff discounted by the 
factor +
2
2
x
x r
. On the other hand, from equation (13) we can write  
c π
1
FPt1
REt
0
REΠ
0t
Π
t?
0
FPΠ
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( )Π = −+0
2 0.5
2
mFP x V c
x r
.        (18) 
Similarly to the RE regime, this can be interpreted as each firm obtaining a lottery with equal 
probabilities of becoming a monopolist and dropping out of the race.  
By comparing equations (17) and (18), it is now clear that the firm’s ex ante profits are 
higher under the RE regime if and only if 
+ ≥(1,1) (1,1)L F mV V V .        (19) 
In other words, this would be the case when the expected payoff of the industry with two 
firms both investing with probability one is higher than the expected payoff of the industry 
with only one firm investing with probability one. Note that the industry with two firms will 
have both higher R&D costs and a higher arrival rate of innovation, resulting in larger total 
profit when the R&D cost is close to zero, as was previously shown.  
This finding that firms may, ex ante, prefer the RE regimes is similar to the result of 
Bessen and Maskin (2006), who show that sometimes firms might prefer a weaker IP regime 
before the start of a race. This result in Bessen and Maskin arises because of the authors’ 
assumption that innovations are complementary (diversity of innovation increases the 
probability of discovery, which is essential to keep the innovation process going). In our 
model, the downside of the FP regime from a firm’s ex ante perspective is that losing the first 
innovation stage forecloses the possibility of profitable innovations in the future. This lost 
opportunity is particularly valuable when the R&D cost is relatively low.  
 
6. Comparing IPR Alternatives: Welfare 
In addition to the profit flowing to the firms, for the welfare comparison of the two IPR 
regimes we need to account for the surplus that flows to consumers whenever an innovation 
is commercialized (recall Figure 1).   
 
6.1. Expected consumer surplus 
Considering the RE regime first, let 0RES  denote the ex ante expected surplus to consumers 
when the IPR system allows for a research exemption. Also, let 1RES  denote the expected 
consumer surplus, under this regime, whenever a successful innovation is achieved. Then 
0
RES  and 1RES  must satisfy the following asset equations: 
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 ( ) ( )σ σ σ= + −+ +
2 1 1
0
2 2 1
2
RE RE
RE
RE RE RE
xS xSS
x r x r
     (20) 
 π= + −1 0 1( )2
RE RE RErS b S S .       (21) 
As can be seen from equation (20), the expected ex ante surplus depends on the number of 
firms investing in R&D. With probability ( )σ 2RE  both firms invest in R&D, and with 
probability ( )σ σ−2 1RE RE  there is a single firm in the race. In the latter case the expected 
time until the arrival of innovation is longer, with instantaneous probability of discovery 
equal to x  (as opposed to 2x  when both firms invest). Equation (21) is a standard Bellman 
equation and represents the flow of consumer surplus from the existing innovation. 
According to this equation, the instantaneous expected return to consumers to having an 
innovation (i.e., 1RErS ) is equal to the flow of consumer surplus while the innovation lasts 
(i.e., π 2 ) plus the expected loss of this surplus due to the possibility of adaptive destruction 
(i.e., −0 1( )RE REb S S ). 
Solving equations (20) and (21) yields 
 
π σ σ
σ σ
⎡ ⎤+ −⎣ ⎦= ⎡ ⎤+ + + − + −⎣ ⎦
2
0 2
(2 ) ( )
( )(2 )( ) 2 (2 ) ( )
RE RERE
RE RE
x x r x
S
r b x r x r bx x r x
.   (22) 
To derive the consumer surplus under the FP alternative, consider the moment at 
which a firm has won the initial R&D contest such that this firm can now market the 
innovation at a profit flow of π  (as long as resistance does not arise). Upon the onset of 
resistance, the FP regime gives the firm the sole right to research for an improvement that 
overcomes the resistance. In such a setting, let 1FPS  denote the expected consumer surplus 
when there is an innovation at hand, and let mS  denote the expected consumer surplus when 
no innovation is available and only one firm (a monopoly) has the right to invest in R&D. 
Then 1FPS  and mS  must satisfy the following asset equations: 
 = +
1
FP
m
xSS
x r
         (23) 
 π= + −1 1( )2
FP FP
mrS b S S .       (24) 
Solving these two equations yields  
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 π +⎛ ⎞= ⎜ ⎟ + +⎝ ⎠1 2 ( )
FP x rS
x r b r
.        (25) 
Now let 0FPS  denote the ex ante expected consumer surplus under the FP regime. Given the 
equilibrium strategy profile, this expected consumer surplus would be equal to 
 ( ) ( )σ σ σ= + −+ +
2 1 1
0
2 2 1
2
FP FP
FP
FP FP FP
xS xSS
x r x r
.     (26) 
Using the solution in equation (25), it follows that 
 σ σπ ⎛ ⎞+ −= ⎜ ⎟+ + +⎝ ⎠
2
0
(2 ) ( )
( ) (2 )
FP FP FPx r xxS
x r b r x r
.     (27) 
The expected consumer surplus is increasing in π  (recall that the instantaneous consumer 
surplus in our model equals π 2 ) and, as one would expect, it is decreasing in the adaptive 
destruction hazard rate.   
 
6.2. Welfare comparison: Analytic results 
By using the foregoing derivation for 0RES  and 0FPS , we can unambiguously rank social 
welfare when the cost of R&D, relative to the potential payoff of the innovation, in not too 
high.   
 
Proposition 4. The RE regime results in a higher level of social welfare if π ∈ ?[0, ]
c t . 
  
To see why this result must hold, evaluate equations (22) and (27) at σ σ= = 1FP RE . It can 
then be verified that when both firms invest with probability one, the consumer surplus 
functions satisfy >0 0(1) (1)RE FPS S , and so we conclude that in the domain of interest, the RE 
regime results in a higher level of social welfare. This result is very intuitive. Because both 
firms invest with probability one under either regime in the domain π ∈ 1[0, ]REc t , the RE 
regime results in a higher rate of innovation for all improvement stages (after the onset of 
resistance), and so in this domain consumers are necessarily better off under the RE regime. 
Furthermore, as long as π ∈ ?[0, ]c t , we have shown that firms also ex ante prefer the RE 
regime. Because <? 1REt t , we can then conclude that in the domain of interest social welfare is 
higher with the RE regime.  
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6.3. Welfare comparison: Numerical results 
Proposition 4 does not rank the two IPR regimes when R&D cost is sufficiently high, that is, 
when π ∈ ? 0[ , ]c t t . To compare social welfare in this domain, we need to take into account 
the types of equilibria that can occur. In particular, we have to distinguish three cases:   
 
(A) π ∈ 1 0( ) [ , ]FPc t t . In this interval, firms’ profits are equal to zero under both regimes, so 
the social welfare under both regimes is equal to the corresponding consumer surplus. 
 
(B) π ∈ 1 1( ) [ , ]RE FPc t t . In this interval, firms make positive profit under the FP regime, and 
social welfare under the FP regime is equal to the sum of profits and consumer surplus. 
 
(C) π ∈ ? 1( ) [ , ]FPc t t . In this interval, firms make positive profit under both regimes, and both 
welfare functions are equal to the sum of profit and consumer surplus. 
 
Because the equilibrium strategies σFP  and σRE  are in general functions of π  and c  
parameters (see the Appendix), it does not appear possible to provide an analytic result that 
would establish unambiguously the welfare ranking of the two IPR regimes. To gain some 
insights, here we resort to comparing welfare numerically. In particular, we normalize profit 
to be equal to one π =( 1)  and study social welfare as a function of c  for a given set of 
parameter values. We calibrate the model so that the resulting durations of an innovation 
race and the useful life of a new variety are broadly consistent with what is observed in the 
plant breeding industry. In particular, we perform our numerical analysis for the following 
parameter values. The discount factor is fixed at = 0.05r . The arrival rate of innovation x  is 
equal to either 0.25 or 0.125, which corresponds to the expected times until discovery of 4 or 
8 years, respectively. The destruction rate b  is equal to 0.2, 0.1, or 0.05, which corresponds 
to the expected lifetime of a new variety of 5, 10, or 20 years, respectively. The resulting 
threshold values (which determine the domains of equilibria A, B, and C for which 
numerical analysis is performed) are given in Table 1. 
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Table 1. Threshold values 
 
= =0.125, 0.1x b  =? 1.32t  =1 2.78REt  =1 3.47FPt  =0 4.76t  
= =0.25, 0.1x b  =? 1.02t  =1 3.03REt  =1 4.05FPt  =0 5.56t  
= =0.125, 0.05x b  =? 1.69t  =1 4.17REt  =1 4.89FPt  =0 7.14t  
= =0.25, 0.05x b  =? 1.22t  =1 4.55REt  =1 5.61FPt  =0 8.33t  
= =0.125, 0.2x b  =? 0.91t  =1 1.67REt  =1 2.19FPt  =0 2.86t  
= =0.25, 0.2x b  =? 0.77t  =1 1.82REt  =1 2.61FPt  =0 3.33t  
 
 
For each pair ( , )x b  we computed the social welfare functions under RE and under the 
FP regimes on the interval ∈ ? 0[ , ]c t t  (we already know the welfare ranking for the range 
∈ ?[0, ]c t  from Proposition 4). These computed welfare levels are graphed in Figure 4, where 
welfare is measured on the vertical axes and R&D cost on the horizontal axes (welfare under 
the RE regimes is represented by the dashed line and welfare under the FP regime is 
represented by the solid line). 
Consistent with what was established in Proposition 4, at = ?c t  social welfare is 
higher under the RE regime. But as c  increases, the numerical analysis shows that at some 
point the FP regime dominates. Hence, this suggests the general conclusion that for the 
parameter values, which reflect the nature of the plant breeding industry, the FP regime is 
socially optimal when the cost of innovation is relatively high. In this case the stronger 
incentives provided by the FP regime lead to a higher flow of innovations and higher social 
welfare. On the other hand, when the cost of R&D is relatively low, a weaker intellectual 
property regime such as RE is beneficial from the social point of view. Additional numerical 
analysis, not reported here for space reasons, shows that this general conclusion appears 
robust to changes in the underlying parameter values well outside the range explored in 
Figure 4.  
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Figure 4. Welfare under FP (solid line) and RE (dashed line) regimes 
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6.4. Licensing 
The model of this article has assumed that the patent-holder does not license its innovation 
to the competitor. It should be clear at the outset that the only meaningful licensing in our 
context is for the right to innovate. Because the model limits the scale of R&D activity, 
theoretically there might be a scope for licensing under the FP regime (under the RE regime 
the follower always has access to innovation by definition). In particular, as shown earlier, 
there exists a region of the parameter space in which the joint profit of the two firms is 
larger than the monopolist’s profit, which would make licensing profitable. Because there is 
no asymmetric information in the model, the monopolist would be able to extract the entire 
expected surplus through licensing. In such a case both expected consumer surplus and 
profit will increase. Hence, licensing would make the total welfare under the FP regime 
higher than without licensing while having no welfare impact under the RE regime. 
Therefore, we conclude that assuming away the possibility of licensing biases our results to 
some degree in favor of the RE regime.    
 
7. Conclusion  
The analysis of this paper contributes to the discussion of economic policies that may 
mitigate problems caused by pest resistance. In contrast to much of the previous literature, 
which deals with this issue within the renewable or non-renewable resource framework, this 
study has focused on the role of an institutional factor that is having an increasing influence 
on the R&D process in plant breeding, namely, the nature of intellectual property rights. In 
particular, we construct an explicit model of the two types of intellectual property regimes 
that are widely used to protect plant innovations and study the effect of the resulting market 
structure on the incentive to invest in plant breeding R&D and social welfare. The two types 
of intellectual property protection in question are those provided by utility patents and those 
provided by Plant Variety Protection certificates. The latter intellectual property regime 
results in a weaker form of protection because it allows for a well-defined research 
exemption provision. We specifically focus on the adaptive destruction process, which arises 
because of the reduction of the market value of the crops due to pest adaptation.  
The model that we have analyzed is necessarily very stylized, yet it yields some 
interesting analytic and numerical results. Specifically, we find that the welfare ranking of the 
intellectual property regimes depends on the cost-to-profit ratio. In our model, the R&D 
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activity requires a fixed outlay at the start of the innovation race, which can be interpreted as 
the cost of starting and maintaining a new plant breeding program. The analytic results 
established in this paper imply that when the cost is relatively low, the research exemption 
regime yields a higher welfare. Our numerical results suggest that for a high cost-to-profit 
ratio it is the full patent regime that provides better incentives to invest in R&D and yields 
higher social welfare. These results are established by calibrating the model so that the 
expected durations of innovation and adaptive destruction processes are broadly 
representative of the plant breeding industry. An additional result established in this paper 
implies that when the value of the cost-to-profit ratio is low, firms ex ante prefer the research 
exemption regime, even though it is a weaker form of protection (this conclusion is similar 
to that obtained by Bessen and Maskin [2002] in a different model of sequential innovation). 
In addition to deriving the profit and welfare effects of alternative intellectual 
property regimes used in the plant breeding, the analysis of this paper also emphasizes that 
the form of intellectual property rights defines the market structure of the industry, and that 
this market structure will not necessarily coincide with the two extreme cases of monopoly 
and perfect competition that have been the focus of the majority of previous studies. Future 
work toward the derivation of cogent implications for policymakers concerned with the 
adaptive destruction problem, therefore, may need to account more explicitly for the 
(sometimes subtle) effects of alternative institutions that establish and strengthen intellectual 
property rights. 
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Appendix 
 
Proof of Proposition 1 (RE regime) 
Substituting (4) and (5) into (3) we obtain 
σ σ σ σπσ σ σ σ σ σ
π σ σσ σ σ σ σ σ
⎛ ⎞ ⎛ ⎞= + + −⎜ ⎟ ⎜ ⎟+ + + + + +⎝ ⎠⎝ ⎠
+⎛ ⎞+ − − + −⎜ ⎟+ +⎝ ⎠
0 0
0
0
( , ) ( , )2( , ) (1 )
(2 ) ( ) (2 ) ( )
( , )
(1 ) ( (1 ) )
i j i j
i j i j i j
i j
j i i j j i
bV bVx x xV
x r r b x r r b x r r b
bVx c
x r r b
 
Rearranging: 
π πσ σ σ σ σ σ σσ σ
⎡ ⎤= + − −⎢ ⎥Φ + + + +⎣ ⎦0
1( , ) (1 )
( , ) (2 ) ( ) ( ) ( )i j i j j i ii j
x xV c
x r r b x r r b
, 
where 
( )σ σ σ σσ σσ σ − + −Φ ≡ − −+ + + +
(1 ) (1 )2
( , ) 1
(2 )( ) ( )( )
i j j ii j
i j
xbxb
x r r b x r r b
. 
Part (i). First note that if σ = 1j , then  
σ πσ σ σ
⎡ ⎤= −⎢ ⎥Φ + +⎣ ⎦0
( , )
( ,1) (2 ) ( )
i
i j
i
xV c
x r r b
. 
Note also that the first term σ σσσ
−⎛ ⎞⎛ ⎞= − +⎜ ⎟⎜ ⎟Φ + + +⎝ ⎠⎝ ⎠
1
1 1
( ,1) ( )( ) 2
i i
i
i
rxb
x r r b x r
, is increasing in 
σ i . This implies that if π>+ +
1
(2 ) ( )
x c
x r r b
 then σ = 1i  is the best response and both firms 
invest with probability 1 in equilibrium. 
Part (ii). For notational simplicity let σ σ≡ *RE . In the interior equilibrium, firm i  is 
indifferent between investing and not for any given σ j . Then the equilibrium symmetric 
strategy σ σ σ= = *i j  must satisfy σ σ=0 0(1, *) (0, *)V V , that is, 
 π πσ σσ
⎡ ⎤+ − − =⎢ ⎥Φ + + + +⎣ ⎦
1 * (1 *) 0
(1, *) (2 ) ( ) ( ) ( )
x x c
x r r b x r r b
  
from which we can solve 
σ π
+ + +⎛ ⎞= −⎜ ⎟⎝ ⎠
(2 ) ( )( )* 1x r c r b x r
x x
. 
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Next, the condition σ< <0 * 1  implies that this solution applies if and only if  
π< <+ + + +( )(2 ) ( )( )
x c x
r b x r r b x r
. 
Part (iii). Note that if σ = 0j  then  
σ πσ σ σ
⎡ ⎤= −⎢ ⎥Φ + +⎣ ⎦0
( , )
( ,0) ( ) ( )
i
i j
i
xV c
x r r b
. 
Clearly, if π<+ +
1
( ) ( )
x c
x r r b
, then σ = 0i  is a best response and none of the firms invests in 
equilibrium.  
 
Proof of Proposition 2 (FP regime) 
Consider the initial stage of the game. For a given strategy profile ( )σ σ ∈ 2, [0,1]i j  the payoff 
of firm i in the initial stage is given by 
σ σ σ σ σ σ⎛ ⎞ ⎛ ⎞= − + − −⎜ ⎟ ⎜ ⎟+ +⎝ ⎠ ⎝ ⎠0( , ) (1 )2
m m
i j i j i j
V x V xV c c
x r x r
, 
where mV  is given by equation (10). Rearranging, 
σσ σ σ ⎛ ⎞⎛ ⎞= − −⎜ ⎟⎜ ⎟⎜ ⎟+ +⎝ ⎠⎝ ⎠0
( , ) 1
2
jm
i j i
xV xV c
x r x r
. 
Part (i). Note that if σ = 1j  we have 
σ σ σ ⎛ ⎞= −⎜ ⎟+⎝ ⎠0( , ) 2
m
i j i
V xV c
x r
. 
This implies that if ≥+2
mV x c
x r
 then σ = 1i  is the best response and both firms invest with 
probability 1 in equilibrium. Substituting for mV  yields 
 π
+≤ + + + + +
( )
(2 )( ) ( )
c x x r
x r x r b r bx x r
. 
Part (ii). For notational simplicity let σ σ≡ *FP . In the interior equilibrium, firm i  is 
indifferent between investing and not for any given σ j . Then the equilibrium symmetric 
strategy profile σ σ σ= = *i j  must satisfy σ σ=0 0(1, *) (0, *)V V , from which we obtain 
σ − + +⎛ ⎞= ⎜ ⎟⎝ ⎠
( ) 2* m
m
V x c x r x r
V x x
. 
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Again, the condition σ< <0 * 1  implies that this solution applies if and only if  
 π
+ < <+ + + + + + +
( )
(2 )( ) ( ) ( )( )
x x r c x
x r x r b r bx x r r b x r
. 
Part (iii). Note that if σ = 0j , then 
 σ σ σ ⎛ ⎞= −⎜ ⎟+⎝ ⎠0( , )
m
i j i
V xV c
x r
. 
This implies that if ≤+
mV x c
x r
 then σ = 0i  is the best response and none of the firms invests 
in equilibrium. This condition can be further simplified, by using the expression for mV , to 
obtain 
 π ≥ + +( )( )
c x
x r r b
.  
 
 
 
